Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.
Role within Screen4Care
Shortening the path to rare diseases diagnosis is a high priority for illumina. Within the Screen4Care project, illumina is an active member of the Ethical Legal and Safety Team (ELST) and its participating in WP1, WP2, WP3, WP4 and WP5. Illumina members take part in the Communication and Dissemination Working Group as well as the Innovation Board.